Thursday, March 12, 2020 | 11:00am ET
For Employers: Coronavirus and Travel: A Complicated Business Decision
The 2019 novel coronavirus outbreak (also known as COVID-19) causes respiratory illness and can spread from person to person. There have been thousands of deaths reported globally, making the coronavirus deadlier than SARS. Coronavirus infections have been reported in dozens of countries. Individuals are being extracted from and departing China and the region, and pandemic fears have also affected shipping and travel around the world. Concerns about the coronavirus have closed factories and forced quarantines throughout China – delaying and even stopping manufacturing and deliveries.
The number of COVID-19 cases in the U.S continues to rise, affecting employers and employees in every industry, from hospitality to manufacturing to health care. What should employers consider in making decisions? This Alston & Bird webinar will review advice we are giving clients related to:
- Travel, both foreign and domestic
- Employee health precautions
- Events and conferences
- Office/workplace visitors
- Remote workforce
- Force majeure and the coronavirus
Our Speakers:
Dawnmarie Matlock regularly advises health care clients on complex regulatory issues, including Stark Law and AntiKickback compliance. She counsels clients facing government investigations and other enforcement actions to mitigate risks and help resolve active matters. She serves as Alston & Bird’s HIPAA privacy officer and counsels clients on HIPAA compliance and breach response.
Angie Burnette assists hospitals, physicians, and other providers with a variety of issues, including those involving medical staff, the National Practitioner Data Bank, mental health, surrogate births, minors, duty to warn, do-not-resuscitate orders, end-of-life issues, and refusal of blood transfusions. Angie provides general risk management and compliance advice to health care facilities, providers, and health plans. She also advises health care providers and non-health-care companies on HIPAA privacy, HIPAA security, and breach notification issues under the HITECH Act and state laws.
Christy Eikhoff will discuss force majeure in light of the coronavirus. She represents clients in significant and high-profile complex commercial litigation matters, with experience in manufacturing, media, and insurance. She is the co-chair of Alston & Bird’s Industrials & Manufacturing Litigation Team. She has handled several multimillion-dollar cases for publicly and privately held entities, with extensive experience in trial, arbitration hearings, mediation, written advocacy, settlement negotiations, and discovery management. Christy has been instrumental in helping business clients achieve resolution in litigated disputes involving claims of breach of contract, fraud, business torts, property torts, defamation, negligence, and unfair and deceptive trade practice and consumer protection statutes.
Charlie Morgan concentrates his practice in litigation and government and internal investigations, including occupational safety and health, employment and traditional labor matters. He represents Fortune 500 companies, retailers, manufacturers and privately held organizations across the U.S. in investigations and litigation involving accidents and safety issues, in class and collection actions, and in anti-union campaigns. He also develops programs and training initiatives for compliance with safety and health laws and federal sentencing guidelines.
Our Experience
Alston & Bird has formed a working group to advise clients on the business and legal implications of the coronavirus. Our multidisciplinary team can assist and advise a broad range of economic sectors on responses to coronavirus news and proactive steps to ensure business continuity, supply-chain alternatives, data security if remote access for all employees is required, and new product development. We regularly work on coronavirus-related issues with the gamut of relevant regulatory bodies as well as congressional policymakers who are leading the response to this fast-moving event. Our team includes members with experience in regulations for employment issues, medical product development, and pharmaceuticals, as well as every type of business interruption scenario. Members of our team have previously worked for, or represent clients before, the White House, Congress, HHS—especially staff and operating divisions such as the Assistant Secretary for Preparedness and Response (ASPR) — FDA, CDC, USDA, EPA, DEA, DOD, SEC, DHS, DOS, and OSHA.
Webinar Details
Thursday, March 12, 2020
Login information will be provided to participants before the program.
Additional Programs
Thursdays | 11:00 am ET
March 19 – For Hospitals, Health Systems, Laboratories and Other Providers: Reimbursement issues, new codes, special employee issues, telemedicine, and how to navigate this new environment.
March 26 – For employers, health plan sponsors and insurers, hospitals, hospitality, and pharmaceutical and medical device manufacturers: What’s still pending on the legislative and regulatory front in response to the coronavirus pandemic.
CLE
These programs are provided as a complimentary service to clients and friends of Alston & Bird. CLE credit is pending for Georgia, Texas, California, New York, Pennsylvania, and Missouri. Additional states may be available upon request.
